Close Menu

NEW YORK (GenomeWeb) – Abbott said Wednesday that its fourth quarter diagnostic revenues grew 52 percent year over year on a reported basis and 7 percent year over year on a comparable operational basis to $1.91 billion from $1.26 billion in the year-ago period.

For the three months ended Dec. 31, 2017, Abbott reported worldwide revenues of $7.59 billion, up 42 percent from $5.33 billion a year ago, and topping the average Wall Street estimate of $7.39 billion. Sales increased 8 percent on a comparable operational basis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.